Skip to main content
AAN.com
Articles
April 1, 1993

The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort
The Rochester Diabetic Neuropathy Study

April 1993 issue
43 (4) 817

Abstract

The magnitude of the health problem from diabetic neuropathies remains inadequately estimated due to the lack of prospective population-based studies employing standardized and validated assessments of the type and stage of neuropathy as compared with background frequency. All Rochester, Minnesota, residents with diabetes mellitus on January 1, 1986, were invited to participate in a cross-sectional and longitudinal study of diabetic neuropathies (and also of other microvascular and macrovascular complications). Of 64,573 inhabitants on January 1, 1986 in Rochester, 870 (1.3%) had clinically recognized diabetes mellitus (National Diabetes Data Group criteria), of whom 380 were enrolled in the Rochester Diabetic Neuropathy Study. Of these, 102 (26.8%) had insulin-dependent diabetes mellitus (IDDM), and 278 (73.2%) had non-insulin-dependent diabetes mellitus (NIDDM). Approximately 10% of diabetic patients had neurologic deficits attributable to nondiabetic causes. Sixty-six percent of IDDM patients had some form of neuropathy; the frequencies of individual types were as follows: polyneuropathy, 54%; carpal tunnel syndrome, asymptomatic, 22%, and symptomatic, 11%; visceral autonomic neuropathy, 7%; and other varieties, 3%. Among NIDDM patients, 59% had various neuropathies; the individual percentages were 45%, 29%, 6%, 5%, and 3%. Symptomatic degrees of polyneuropathy occurred in only 15% of IDDM and 13% of NIDDM patients. The more severe stage of polyneuropathy, to the point that patients were unable to walk on their heels and also had distal sensory and autonomic deficits (stage 2b) occurred even less frequently–6% of IDDM and 1% of NIDDM patients. Overall, two thirds of diabetic patients have objective evidence for some variety of neuropathy, but only about 20% have symptoms, and only 6% of IDDM and only 1% of NIDDM patients have sufficiently severe polyneuropathy to be graded stage 2b, and none were graded stage 3. Approximately one quarter of patients had subclinical carpal tunnel syndrome, but only 7.7% had symptomatic carpal tunnel syndrome. Thus, diabetic peripheral neuropathy is frequent but less severe than generally thought. As generally believed, however, neuropathy, retinopathy, and nephropathy are significantly associated.

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors

Information

Published In

Neurology®
Volume 43Number 4April 1993
Pages: 817
PubMed: 8469345

Publication History

Published online: April 1, 1993
Published in print: April 1993

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

P. J. Dyck, MD
Peripheral Neuropathy Research Center, Department of Neurology (K.M. Kratz, J.L. Karnes, and Drs. Dyck and Litchy), the Department of Internal Medicine, Division of Nephrology (Dr. Wilson), the Department of Ophthalmology (Dr. Pach), the Section of Biostatistics (Dr. O'Brien), and the Section of Clinical Epidemiology (Dr. Melton), Mayo Clinic and Mayo Foundation, Rochester, MN; and the Department of Ophthalmology and Center for Biostatistics (Dr. Klein), University of Wisconsin, Madison, WI.
K. M. Kratz
Peripheral Neuropathy Research Center, Department of Neurology (K.M. Kratz, J.L. Karnes, and Drs. Dyck and Litchy), the Department of Internal Medicine, Division of Nephrology (Dr. Wilson), the Department of Ophthalmology (Dr. Pach), the Section of Biostatistics (Dr. O'Brien), and the Section of Clinical Epidemiology (Dr. Melton), Mayo Clinic and Mayo Foundation, Rochester, MN; and the Department of Ophthalmology and Center for Biostatistics (Dr. Klein), University of Wisconsin, Madison, WI.
J. L. Karnes, MS
Peripheral Neuropathy Research Center, Department of Neurology (K.M. Kratz, J.L. Karnes, and Drs. Dyck and Litchy), the Department of Internal Medicine, Division of Nephrology (Dr. Wilson), the Department of Ophthalmology (Dr. Pach), the Section of Biostatistics (Dr. O'Brien), and the Section of Clinical Epidemiology (Dr. Melton), Mayo Clinic and Mayo Foundation, Rochester, MN; and the Department of Ophthalmology and Center for Biostatistics (Dr. Klein), University of Wisconsin, Madison, WI.
W. J. Litchy, MD
Peripheral Neuropathy Research Center, Department of Neurology (K.M. Kratz, J.L. Karnes, and Drs. Dyck and Litchy), the Department of Internal Medicine, Division of Nephrology (Dr. Wilson), the Department of Ophthalmology (Dr. Pach), the Section of Biostatistics (Dr. O'Brien), and the Section of Clinical Epidemiology (Dr. Melton), Mayo Clinic and Mayo Foundation, Rochester, MN; and the Department of Ophthalmology and Center for Biostatistics (Dr. Klein), University of Wisconsin, Madison, WI.
R. Klein, MD, MPH
Peripheral Neuropathy Research Center, Department of Neurology (K.M. Kratz, J.L. Karnes, and Drs. Dyck and Litchy), the Department of Internal Medicine, Division of Nephrology (Dr. Wilson), the Department of Ophthalmology (Dr. Pach), the Section of Biostatistics (Dr. O'Brien), and the Section of Clinical Epidemiology (Dr. Melton), Mayo Clinic and Mayo Foundation, Rochester, MN; and the Department of Ophthalmology and Center for Biostatistics (Dr. Klein), University of Wisconsin, Madison, WI.
J. M. Pach, MD
Peripheral Neuropathy Research Center, Department of Neurology (K.M. Kratz, J.L. Karnes, and Drs. Dyck and Litchy), the Department of Internal Medicine, Division of Nephrology (Dr. Wilson), the Department of Ophthalmology (Dr. Pach), the Section of Biostatistics (Dr. O'Brien), and the Section of Clinical Epidemiology (Dr. Melton), Mayo Clinic and Mayo Foundation, Rochester, MN; and the Department of Ophthalmology and Center for Biostatistics (Dr. Klein), University of Wisconsin, Madison, WI.
D. M. Wilson, MD
Peripheral Neuropathy Research Center, Department of Neurology (K.M. Kratz, J.L. Karnes, and Drs. Dyck and Litchy), the Department of Internal Medicine, Division of Nephrology (Dr. Wilson), the Department of Ophthalmology (Dr. Pach), the Section of Biostatistics (Dr. O'Brien), and the Section of Clinical Epidemiology (Dr. Melton), Mayo Clinic and Mayo Foundation, Rochester, MN; and the Department of Ophthalmology and Center for Biostatistics (Dr. Klein), University of Wisconsin, Madison, WI.
P. C. O'Brien, PhD
Peripheral Neuropathy Research Center, Department of Neurology (K.M. Kratz, J.L. Karnes, and Drs. Dyck and Litchy), the Department of Internal Medicine, Division of Nephrology (Dr. Wilson), the Department of Ophthalmology (Dr. Pach), the Section of Biostatistics (Dr. O'Brien), and the Section of Clinical Epidemiology (Dr. Melton), Mayo Clinic and Mayo Foundation, Rochester, MN; and the Department of Ophthalmology and Center for Biostatistics (Dr. Klein), University of Wisconsin, Madison, WI.
L. J. Melton, III, MD
Peripheral Neuropathy Research Center, Department of Neurology (K.M. Kratz, J.L. Karnes, and Drs. Dyck and Litchy), the Department of Internal Medicine, Division of Nephrology (Dr. Wilson), the Department of Ophthalmology (Dr. Pach), the Section of Biostatistics (Dr. O'Brien), and the Section of Clinical Epidemiology (Dr. Melton), Mayo Clinic and Mayo Foundation, Rochester, MN; and the Department of Ophthalmology and Center for Biostatistics (Dr. Klein), University of Wisconsin, Madison, WI.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Role of biochemical parameters in prediction of diabetic peripheral neuropathy, Journal of Research in Applied and Basic Medical Sciences, 10, 2, (169-177), (2024).https://doi.org/10.61186/rabms.10.2.169
    Crossref
  2. Surgical management of the diabetic foot: The current evidence, World Journal of Orthopedics, 15, 5, (404-417), (2024).https://doi.org/10.5312/wjo.v15.i5.404
    Crossref
  3. Application Progress of Ultrasound Elastography in the Evaluation of Diabetic Peripheral Neuropathy, ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY, 8, 1, (1), (2024).https://doi.org/10.37015/AUDT.2024.230006
    Crossref
  4. Multifractal Heart Rate Value Analysis: A Novel Approach for Diabetic Neuropathy Diagnosis, Healthcare, 12, 2, (234), (2024).https://doi.org/10.3390/healthcare12020234
    Crossref
  5. Prevalence of Distal Symmetrical Polyneuropathy by Diabetes Prevention Program Treatment Group, Diabetes Status, Duration of Diabetes, and Cumulative Glycemic Exposure, Diabetes Care, 47, 5, (810-817), (2024).https://doi.org/10.2337/dc23-2009
    Crossref
  6. Neuropathic Pain in Aged People: An Unresolved Issue Open to Novel Drug Approaches, Focusing on Painful Diabetic Neuropathy, Current Neuropharmacology, 22, 1, (53-64), (2024).https://doi.org/10.2174/1570159X21666230807103642
    Crossref
  7. A clinicoepidemiological study of pattern of skin disorders among diabetes mellitus in a tertiary care centre, IP Indian Journal of Clinical and Experimental Dermatology, 10, 1, (51-59), (2024).https://doi.org/10.18231/j.ijced.2024.009
    Crossref
  8. An updated review on diabetes mellitus: Exploring its etiology, pathophysiology, complications and treatment approach, IP International Journal of Comprehensive and Advanced Pharmacology, 9, 1, (31-36), (2024).https://doi.org/10.18231/j.ijcaap.2024.005
    Crossref
  9. Efficacy of a Tailored COMET Protocol Combined with Medication on Vibratory Perception and SkinConductance in Diabetic Neuropathy- A Protocol for Randomized Controlled Trial, F1000Research, 13, (344), (2024).https://doi.org/10.12688/f1000research.144809.1
    Crossref
  10. Simplified electrophysiological approach combining a point‐of‐care nerve conduction device and an electrocardiogram produces an accurate diagnosis of diabetic polyneuropathy, Journal of Diabetes Investigation, 15, 6, (736-742), (2024).https://doi.org/10.1111/jdi.14174
    Crossref
  11. See more
Loading...

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to access the full text.

Purchase Access, $39 for 24hr of access

View options

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Share article link

Share